Methenamine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others), By Sales Channel (Direct Sale and Indirect Sale), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	520.77 Thousand Tonnes
CAGR (2026-2031)	3.59%
Fastest Growing Segment	Synthetic Resin
Largest Market	Asia Pacific
Market Size (2031)	643.51 Thousand Tonnes

Market Overview

The Global Methenamine Market will grow from 520.77 Thousand Tonnes in 2025 to 643.51 Thousand Tonnes by 2031 at a 3.59% CAGR. Methenamine, chemically known as hexamethylenetetramine, is a heterocyclic organic compound synthesized through the condensation reaction of formaldehyde and ammonia. The market’s growth is fundamentally supported by the expansion of the automotive and construction sectors, where the product serves as an essential curing agent for phenolic resins and molding compounds. Furthermore, sustained demand from the pharmaceutical industry for urinary antiseptics and the rubber industry for vulcanization accelerators acts as a primary economic driver, ensuring consistent industrial consumption distinct from transient market preferences.

However, a significant challenge impeding market expansion is the implementation of stringent environmental regulations regarding formaldehyde emissions, as methenamine releases this hazardous substance during thermal decomposition. Despite these regulatory pressures, the upstream supply chain for necessary feedstocks remains robust. According to the Methanol Institute, in 2025, the global industry tracked 252 renewable methanol projects with a total anticipated capacity of 45.1 million metric tons by 2030, indicating a strengthening raw material base for downstream derivatives like methenamine.

Key Market Drivers

The expansion of the construction and furniture sectors significantly propels the market, particularly through the demand for phenolic resins where methenamine serves as an essential curing agent. These resins are critical binders in the manufacturing of wood-based panels, including plywood, particleboard, and medium-density fiberboard (MDF), which are foundational to infrastructure and housing projects. As urbanization accelerates, the consumption of these engineered wood products rises, directly scaling the requirement for methenamine to ensure the structural integrity and moisture resistance of the final boards. According to the European Panel Federation, July 2025, in the 'Annual Report 2024-2025', total European wood-based panel production recovered to reach 58.1 million cubic meters in 2024, representing a 2.7% increase that underscores the resurgence in resin demand.

Increasing automotive production further boosts consumption, primarily driven by the need for rubber vulcanization accelerators in tire manufacturing. Methenamine acts as a methylene donor in the vulcanization process, enhancing the thermal stability and durability of rubber compounds used in tires, weather stripping, and vibration mounts. This application is heavily reliant on the volume of new vehicle assembly and the replacement tire market. According to the China Association of Automobile Manufacturers, January 2025, in the '2024 Automobile Production and Sales' report, annual vehicle production in China hit a record 31.28 million units, creating substantial demand for rubber processing chemicals. Supporting this industrial outlook, the American Chemistry Council, February 2025, in the 'Chemical Manufacturing Economic Sentiment Index' report, noted that chemical manufacturers expect solid demand improvement in the US market for 2025, signaling a positive trajectory for upstream chemical suppliers.

Download Free Sample Report

Key Market Challenges

The implementation of stringent environmental regulations regarding formaldehyde emissions stands as a critical barrier to the growth of the Global Methenamine Market. Because methenamine functions by releasing formaldehyde during thermal decomposition or hydrolysis—the exact mechanism that makes it effective as a curing agent and urinary antiseptic—it is inherently vulnerable to policies targeting hazardous air pollutants and occupational carcinogens. As regulatory frameworks tighten globally to minimize health risks, compliance becomes increasingly capital-intensive, forcing manufacturers to invest heavily in containment technologies or pushing end-use industries toward alternative, less regulated substitutes.

This regulatory tightening is exerting measurable pressure on key application sectors, particularly within regions prioritizing occupational safety. According to Formacare, in 2024, the European medical and healthcare sectors were legally required to adhere to a stricter Binding Occupational Exposure Limit (BOEL) for formaldehyde of 0.3 parts per million (ppm) following the expiration of a transitional exemption period. Such restrictive numerical caps on formaldehyde exposure directly constrain the operational flexibility of methenamine in pharmaceutical and industrial settings, effectively dampening market potential despite the robust availability of upstream feedstocks.

Key Market Trends

The market is witnessing a strategic shift toward non-antibiotic prophylaxis for recurrent urinary tract infections (UTIs) to combat antimicrobial resistance. Methenamine hippurate is gaining clinical preference as a urinary antiseptic that hydrolyzes into bacteriocidal formaldehyde, effectively avoiding the resistance issues associated with standard antibiotics. This trend is driving the commercialization of generic formulations, thereby increasing the volumetric consumption of pharmaceutical-grade methenamine. According to Zydus Lifesciences, March 2025, in the company's 'USFDA Approval Announcement', annual sales for methenamine hippurate tablets in the United States reached $32.6 million for the period ending January 2025, underscoring the growing market value of this therapeutic class.

Concurrently, the agricultural sector is intensifying the adoption of slow-release nitrogen fertilizers, utilizing methenamine as a key intermediate in the synthesis of methylene urea. These advanced fertilizers are critical for sustainable agriculture, as they reduce nitrogen volatilization and leaching compared to conventional urea, directly addressing environmental concerns regarding soil health. This segment is supported by a resurgence in global agricultural input demand. According to the International Fertilizer Association, December 2024, in the 'Medium-Term Fertilizer Outlook 2024-2028', global fertilizer consumption was forecast to recover to 203.7 million metric tons of nutrients in 2024, indicating a strengthening platform for the adoption of methenamine-based efficiency technologies.

Segmental Insights

The Synthetic Resin segment represents the fastest-growing category within the Global Methenamine Market, driven by the substantial demand for phenolic and melamine resins. Methenamine functions as a vital curing agent in these compounds, imparting essential thermal stability and mechanical strength. This chemical utility is critical for the automotive sector, particularly in manufacturing heat-resistant brake linings and clutch facings, as well as the construction industry for producing durable laminates and adhesives. Consequently, persistent expansion in global infrastructure and automotive production continues to accelerate the adoption of methenamine-based synthetic resins.

Regional Insights

Asia Pacific maintains a dominant position in the global methenamine market, driven by substantial manufacturing output in China and India. The region experiences high demand for phenolic resins and rubber accelerators, which are critical components for the expanding construction and automotive industries. This consumption is directly linked to rapid urbanization and infrastructure development, which necessitate large volumes of cured plastics and bonded materials. Additionally, the concentration of key chemical producers within the region ensures a robust supply chain, effectively supporting local industrial requirements and cementing Asia Pacific as the principal market leader.

Recent Developments

• In September 2025, Cipla Limited launched a new pharmaceutical product containing methenamine hippurate under the brand name HUENA in the Indian market. This introduction marked the release of a non-antibiotic treatment option designed for patients suffering from recurrent urinary tract infections. The launch was positioned as a strategic move to combat antimicrobial resistance by providing an effective alternative to conventional antibiotics. Company executives highlighted that the product would help reduce the reliance on antibiotics for long-term therapy, thereby improving patient outcomes and contributing to antimicrobial stewardship in the region's healthcare landscape.
• In March 2025, Zydus Lifesciences received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Methenamine Hippurate Tablets USP, 1 gram. The approval allowed the pharmaceutical company to produce the generic equivalent of Hiprex tablets, which are indicated for the prophylactic or suppressive treatment of frequently recurring urinary tract infections. The product was scheduled to be manufactured at the company's formulation manufacturing facility in Ahmedabad, India. This regulatory milestone expanded the company's portfolio of offerings in the US market, addressing the therapeutic needs of patients requiring long-term treatment for urinary tract infections.
• In November 2024, the Methanol Chemicals Company (Chemanol) entered into a long-term collaboration with Air Products Qudra to modernize its industrial operations. The twenty-year supply agreement focused on the provision of essential industrial gases required to upgrade Chemanol’s manufacturing facilities, which produce methanol and its derivatives such as hexamine. This partnership was established to improve operational efficiency and secure a reliable source of high-quality gases, aligning with the company's broader strategy to enhance its competitive edge in the specialty chemicals sector. The deal represented a significant step in the company's efforts to optimize its production processes.
• In September 2024, Kanoria Chemicals & Industries Limited inaugurated a new hexamine manufacturing facility at its Ankleshwar site in Gujarat, India. This strategic expansion involved the commissioning of a plant with a production capacity of 18 Metric Tons Per Day (MTPD), which effectively doubled the company's overall hexamine output to 36 MTPD. The facility was designed to utilize indigenous technology to meet the growing demand from various downstream sectors, including phenolic resins, explosives, and pharmaceuticals. This development underscored the company's commitment to strengthening its position in the domestic and international chemical markets through capacity enhancement.

Key Market Players

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co.,Ltd
• Guangzhou Hanpu Pharmaceutical Co Ltd
• Zaozhuang xudong chemical technology co., ltd.
• Simalin Chemical Industries Private Limited

By End-Use	By Sales Channel	By Region
Synthetic Resin Rubber Industry Textile Industry and Others	Direct Sale and Indirect Sale	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Methenamine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Methenamine Market , By End-Use:

• Synthetic Resin
• Rubber Industry
• Textile Industry
• and Others

• Methenamine Market , By Sales Channel:

• Direct Sale and Indirect Sale

• Methenamine Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE